Provided by Tiger Trade Technology Pte. Ltd.

Mereo Biopharma Group Plc

0.3360
-0.0066-1.93%
Post-market: 0.33790.0019+0.57%19:51 EDT
Volume:1.53M
Turnover:515.74K
Market Cap:53.47M
PE:-1.28
High:0.3460
Open:0.3340
Low:0.3293
Close:0.3426
52wk High:3.05
52wk Low:0.2000
Shares:159.13M
Float Shares:100.47M
Volume Ratio:0.91
T/O Rate:1.52%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2629
EPS(LYR):-0.2627
ROE:-82.21%
ROA:-39.10%
PB:1.31
PE(LYR):-1.28

Loading ...

Critica Advances Jupiter Rare Earths Project as Australia’s Largest Clay-Hosted MREO Resource

TIPRANKS
·
6 hours ago

Shareholders Sue Mereo BioPharma (MREO) Over Brittle Bone Drug Claims

TIPRANKS
·
Yesterday

Mereo BioPharma Group PLC reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 23

Mereo BioPharma downgraded to Neutral from Overweight at JPMorgan

TIPRANKS
·
Mar 23

Mereo Biopharma Group Plc : JP Morgan Cuts to Neutral From Overweight

THOMSON REUTERS
·
Mar 23

Mereo BioPharma downgraded to Neutral from Overweight at JPMorgan

TIPRANKS
·
Mar 21

Mereo BioPharma Group PLC expected to post breakeven results a share - Earnings Preview

Reuters
·
Mar 20

Mereo BioPharma Group Q4 EPS $(0.01), Inline

Benzinga
·
Mar 19

UK's Mereo BioPharma misses 2025 revenue estimates, expects cash runway to mid-2027

Reuters
·
Mar 19

Mereo BioPharma FY Revenue USD 500 Thousand Vs. IBES Estimate USD 520 Thousand

Reuters
·
Mar 19

Mereo BioPharma FY 2025 cash and cash equivalents fall 41.28% to USD 40.99 million

Reuters
·
Mar 19

Press Release: Mereo BioPharma Reports Full Year 2025 Financial Results and Provides Corporate Highlights

Dow Jones
·
Mar 19

European Equities Traded in US as ADRs Fall in Wednesday Trading

MT Newswires Live
·
Mar 18

Mereo BioPharma faces securities class action over setrusumab bone mineral density claims

Reuters
·
Mar 18

European Equities Traded in the US as American Depositary Receipts Decline in Friday Trading

MT Newswires Live
·
Mar 14

Class Action Lawsuit Targets Mereo BioPharma Over Allegedly Misleading Trial Claims

Reuters
·
Mar 14

Mereo BioPharma CEO and CSO named as defendants in securities class action

Reuters
·
Mar 11

European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading

MT Newswires Live
·
Mar 09

Rosen Law Firm Urges Mereo BioPharma ADS Investors to Act by April 6 Lead Plaintiff Deadline

Reuters
·
Mar 05

Robbins LLP Files Class Action Against Mereo BioPharma Group plc

Reuters
·
Mar 05